TLR4 and early-onset autosomal dominant Alzheimer disease: In addition, TLR4-deficient mice displayed increases in diffuse amyloid beta-protein and its deposits compared with WT mice [11], suggesting that TLR4 signaling might be involved in Alzheimer's disease progression and could be a new therapeutic target for Alzheimer's disease [12].